Find similar content

Source channel @githubtrending · Post #15432 · Jan 23

#jupyter_notebook#chinese_llm#chinese_nlp#finetune#generative_ai#instruct_gpt#instruction_set#llama#llm#lora#open_models#open_source#open_source_models#qlora AirLLM is a tool that lets you run very large AI models on computers with limited memory by using a smart layer-by-layer loading technique instead of traditional compression methods. You can run a 70-billion-parameter model on just 4GB of GPU memory, or even a 405-billion-parameter model on 8GB, without losing model quality. The benefit is that you can use powerful AI models on affordable hardware without expensive upgrades, and the tool also offers optional compression features that can speed up performance by up to 3 times while maintaining accuracy. https://github.com/lyogavin/airllm

Hashtags

#jupyter_notebook #chinese_llm #chinese_nlp #finetune #generative_ai #instruct_gpt #instruction_set #llama #llm #lora #open_models #open_source #open_source_models #qlora

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment